```html

Quartered Vision (Quadrantanopia)

What is Quartered Vision (Quadrantanopia)?

Quadrantanopia, often called “quartered vision,” is a visual field defect in which a person loses vision in one quarter (or “quadrant”) of the visual field in one or both eyes. The loss can involve the upper or lower, left or right quadrant. Because each eye’s nasal and temporal retina project to opposite halves of the brain, damage to specific pathways can produce a precise, wedge‑shaped blind spot rather than complete blindness.

People with quadrantanopia usually have normal visual acuity (sharpness) when looking straight ahead, but they cannot see objects that fall within the affected quadrant, even though the eye itself is healthy. The defect is typically “respectful” of the vertical or horizontal meridian, meaning a clear line separates the lost field from the intact field.

Common Causes

The visual pathway is long and involves the retina, optic nerve, optic chiasm, optic tract, lateral geniculate nucleus (LGN), optic radiations, and visual cortex. Damage at any point can create a quadrantanopia. Below are the most frequent etiologies:

• Posterior Cerebral Artery (PCA) Stroke – infarcts in the occipital lobe often cause a contralateral homonymous quadrantanopia.
• Temporal Lobe Tumors – meningiomas or gliomas compressing Meyer’s loop (inferior optic radiations) produce a superior quadrantanopia (“pie in the sky”).
• Parietal Lobe Lesions – infarcts, hemorrhages, or metastases affecting the dorsal optic radiations cause an inferior quadrantanopia.
• Multiple Sclerosis (MS) – demyelinating plaques in the optic radiations can produce transient or permanent quadrant loss.
• Traumatic Brain Injury (TBI) – shearing forces may damage the optic radiations or occipital cortex.
• Infections – brain abscesses, herpes encephalitis or tuberculous meningitis affecting posterior cortical areas.
• Neurodegenerative Disorders – advanced Alzheimer’s disease or Lewy body dementia can involve occipital cortices.
• Glaucoma (advanced) – severe peripheral field loss can mimic quadrant defects, though true quadrantanopia is rare.
• Congenital Anomalies – rare developmental malformations of the optic radiations.
• Radiation Therapy – damage to optic pathways after treatment for head‑and‑neck cancers.

Associated Symptoms

Because quadrantanopia results from central nervous system injury, it is usually accompanied by other neurological signs. Common co‑occurring symptoms include:

• Headache or sudden onset severe headache (especially with stroke or hemorrhage)
• Difficulty reading, especially lines that fall in the affected quadrant
• Problems with navigation or bumping into objects on the blind side
• Hemispatial neglect (ignoring the side of space opposite the lesion)
• Eye movement abnormalities (nystagmus, diplopia)
• Weakness or numbness on the same side of the body (hemiparesis/hemisensory loss)
• Speech or language changes when the dominant hemisphere is involved
• Memory or cognitive changes if the lesion extends to adjacent cortical areas

When to See a Doctor

Any sudden change in vision warrants prompt evaluation. Seek medical attention if you notice:

• Sudden loss of vision in a quarter of the visual field.
• Accompanying neurological signs (weakness, numbness, speech difficulty).
• Severe headache, especially with neck stiffness.
• Visual disturbances after a head injury.
• Progressive loss of vision over days to weeks.
• Persistent visual “blind spots” that do not resolve within a few hours.

Early evaluation is crucial because many underlying causes (stroke, tumor, infection) are time‑sensitive.

Diagnosis

Diagnosing quadrantanopia involves a combination of bedside testing and advanced imaging.

1. History & Physical Examination

• Detailed symptom timeline (onset, progression, triggers).
• Review of vascular risk factors (hypertension, diabetes, smoking).
• Neurological exam for motor, sensory, language, and coordination deficits.

2. Visual Field Testing

• Confrontation test – quick bedside screen where the examiner compares the patient’s visual fields.
• Automated perimetry (e.g., Humphrey Visual Field Analyzer) – provides a precise map of the defect.

3. Imaging Studies

• CT scan – fast, useful for acute hemorrhage or large infarcts.
• MRI with diffusion‑weighted imaging – gold standard for detecting acute ischemia, demyelination, or tumor.
• MR angiography/CT angiography – assesses the posterior cerebral artery and other vessels.

4. Additional Tests (as indicated)

• Blood work: CBC, electrolytes, coagulation profile, inflammatory markers.
• Lumbar puncture if infection or inflammatory disease is suspected.
• Ophthalmologic exam to rule out retinal or optic‑nerve disease.

Treatment Options

Treatment is directed at the underlying cause; the visual field defect itself may improve, remain stable, or be permanent.

Acute Management

• Ischemic stroke – intravenous thrombolysis (tPA) within 4.5 hours, followed by antiplatelet therapy and risk‑factor control (AHA/ASA guidelines).
• Hemorrhagic stroke – blood pressure control, neurosurgical evacuation if indicated.
• Brain tumor – surgical resection, radiotherapy, or chemotherapy based on histology.
• Infection – appropriate antimicrobial therapy (e.g., IV ceftriaxone for bacterial abscess, acyclovir for herpes encephalitis).
• MS flare – high‑dose IV methylprednisolone, followed by disease‑modifying therapy.

Rehabilitation & Symptom‑Focused Care

• Low‑vision therapy – prism glasses, tinted lenses, or electronic visual aids to enlarge the remaining field.
• Occupational therapy – training for safe navigation, hazard detection, and adaptive strategies for daily tasks.
• Compensatory scanning training – teaches patients to consciously look toward the blind quadrant.
• Neuro‑visual rehabilitation – evidence‑based programs (e.g., visual restitution therapy) that may promote cortical re‑organization.

Long‑Term Management

• Control vascular risk factors: blood pressure < 130/80 mm Hg, LDL < 70 mg/dL, smoking cessation.
• Regular ophthalmology follow‑up to monitor for progression.
• Medication adherence for chronic conditions (anticoagulation for atrial fibrillation, disease‑modifying drugs for MS).

Prevention Tips

While not all causes are preventable, many can be reduced through lifestyle and medical measures:

• Maintain cardiovascular health – diet rich in fruits, vegetables, whole grains; regular aerobic exercise; weight control.
• Manage hypertension, diabetes, and hyperlipidemia – regular check‑ups, medication adherence.
• Avoid smoking and excessive alcohol – both increase stroke risk.
• Protect the head – wear helmets during high‑risk activities; use seat belts.
• Promptly treat infections – especially sinusitis or ear infections that could spread to the brain.
• Adhere to MS disease‑modifying therapy – reduces relapse rates and demyelinating lesions.
• Routine eye examinations – ensure that peripheral field loss isn’t due to glaucoma or retinal disease.

Emergency Warning Signs

Key Take‑aways

Quadrantanopia is a distinct visual field defect that signals injury to the visual pathways, most often from a stroke or brain tumor. Early recognition, rapid imaging, and treatment of the underlying cause improve the chance of visual recovery and prevent permanent disability. If you notice a sudden “blind spot” occupying a quarter of your view, seek medical attention right away.

---

References:

• American Heart Association/American Stroke Association. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2022.
• Mayo Clinic. “Quadrantanopia.” mayoclinic.org. Accessed June 2026.
• National Institute of Neurological Disorders and Stroke. “Visual Field Defects.” NIH, 2023.
• Cleveland Clinic. “Brain Tumors and Vision Changes.” 2024.
• World Health Organization. “Global Best Practices for Stroke Care.” WHO, 2021.

```